Moderna to supply 100 to 125 million COVID-19 vaccine doses globally in first quarter
Vials of coronavirus vaccine and a syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. (Reuters)
Moderna Inc said on Thursday it expects to have between 100 million and 125 million doses of its COVID-19 vaccine available globally in the first quarter of 2021.
The company said 85 million to 100 million of those doses would be available in the United States, with 15 million to 25 million outside the country.
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
